The median survival of glioblastoma patients is∼ 12 months. However, 3–5% of the patients
survives for more than 3 years and are referred to as long-term survivors. The clinical and …

Treatment-induced CNS toxicity remains a major cause of morbidity in patients with cancer.
Advances in the design of safe radiation procedures have been counterbalanced by …

Standard therapeutic options for brain tumors include surgery, radiation, and chemotherapy.
Unfortunately, these same therapies pose risks of neurotoxicity, the most common long-term …

Patients with brain metastases are now eligible for a number of treatment options that are
increasingly likely to improve outcomes. Randomized, prospective trials are necessary to …

With advances in stereotactic and neuroimaging techniques, various minimally invasive
image-guided techniques have gained widespread acceptance in the field of neuro …

Object This study evaluated the efficacy of postoperative Gamma Knife surgery (GKS) to the
tumor cavity following gross-total resection of a brain metastasis. Methods A retrospective …

Delayed radiation necrosis is a well-known adverse event following radiotherapy for brain
diseases and has been studied since the 1930s. The primary pathogenesis is thought to be …

Brain metastasis is the most common intracranial tumor in adults. Currently, treatment of
brain metastasis requires multidisciplinary approach tailored for each individual patient …

The aim of this study is to analyse the efficacy of linear accelerator stereotactic radiosurgery
(SRS) on prognostic factors, local control rate and survival in patients with brain metastasis …

Cerebral radiation‐induced injury ranges from acute reversible edema to late irreversible
radiation necrosis (RN). Cerebral RN is poorly responsive to treatment, is associated with …